Evidence map›Paper›PMID 31529466›Full record

ReviewActa obstetricia et gynecologica Scandinavica2020

Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy.

Charlotte Maggen, Christianne A Lok, Elyce Cardonick, Mathilde van Gerwen, Petronella B Ottevanger, Ingrid A Boere, Martin Koskas, Michael J Halaska, Robert Fruscio, Mina M Gziri and 4 more

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Acta obstetricia et gynecologica Scandinavica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Pregnancy and Gastric Cancer: A Narrative Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Review
  11. Gastrointestinal malignancies in pregnancy.Abdominal radiology (New York) · 2023
    Review
  12. Article
  13. Article
  14. Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 6 countries.

Charlotte MaggenDepartment of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
Christianne A LokCenter for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands.
Elyce CardonickDepartment of Obstetrics and Gynecology, Cooper, University Health Care, Camden, NJ, USA.
Mathilde van GerwenCenter for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands.
Petronella B OttevangerDepartment of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Ingrid A BoereDepartment of Medical Oncology, Erasmus MC Cancer, Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Martin KoskasGynecologic Oncology, Bichat University Hospital, Paris Diderot University, Paris, France.
Michael J HalaskaFaculty Hospital Kralovske, Vinohrady and 3rd Medical Faculty, Charles University, Prague, Czech Republic.
Robert FruscioClinic of Obstetrics and Gynecology, University of Milan - Bicocca, San Gerardo Hospital, Monza, Italy.
Mina M GziriDepartment of Obstetrics, Cliniques Universitaires St Luc, UCL, Sint-Lambrechts-Woluwe, Belgium.
Petronella O WitteveenDepartment of Medical Oncology, Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Kristel Van CalsterenDepartment of Obstetrics, University Hospitals Leuven, Leuven and Department of Development and regeneration, KU Leuven, Leuven, Belgium.
Frédéric AmantDepartment of Oncology, KU Leuven, Leuven, Belgium.ORCID 0000-0002-5452-4905
International Network on Cancer, Infertility and Pregnancy (INCIP)
The Netherlands Cancer Institute · NLKU Leuven · BECharles University · CZCliniques Universitaires Saint-Luc · BECooper University Health Care · USDélégation Paris 7 · FRErasmus MC · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLUniversity of Milano-Bicocca · IT

Funding

Charles UniversityEuropean Society of Gynecological OncologyFonds Wetenschappelijk Onderzoek G070514NH2020 European Research Council 647047Kralovske Vinohrady University Hospital 00064173
6 · The paper itself

Abstract

introductionGastric cancer during pregnancy is extremely rare and data on optimal treatment and possible chemotherapeutic regimens are scarce. The aim of this study is to describe the obstetric and maternal outcome of women with gastric cancer during pregnancy and review the literature on antenatal chemotherapy for gastric cancer. MATERIAL AND

methodsTreatment and outcome of patients registered in the International Network on Cancer, Infertility and Pregnancy database with gastric cancer diagnosed during pregnancy were analyzed.

resultsIn total, 13 women with gastric cancer during pregnancy were registered between 2002 and 2018. Median gestational age at diagnosis was 22 weeks (range 6-30 weeks). Twelve women were diagnosed with advanced disease and died within 2 years after pregnancy, most within 6 months. In total, eight out of 10 live births ended in a preterm delivery because of preeclampsia, maternal deterioration, or therapy planning. Two out of six women who initiated chemotherapy during pregnancy delivered at term. Two neonates prenatally exposed to chemotherapy were growth restricted and one of them developed a systemic infection with brain abscess after preterm delivery for preeclampsia 2 weeks after chemotherapy. No malformations were reported.

conclusionsThe prognosis of gastric cancer during pregnancy is poor, mainly due to advanced disease at diagnosis, emphasizing the need for early diagnosis. Antenatal chemotherapy can be considered to reach fetal maturity, taking possible complications such as growth restriction, preterm delivery, and hematopoietic suppression at birth into account.

Indexed as

Pregnancy OutcomePrenatal Exposure Delayed EffectsAdultAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsFemaleFetal Growth RetardationHumansInfant, NewbornMaternal-Fetal ExchangePre-EclampsiaPregnancyPregnancy Complications, NeoplasticPremature BirthStomach NeoplasmsAntineoplastic Agentschemotherapygastric cancermaternal outcomeobstetric outcomepregnancy

Identifiers

PMID31529466
PMCPMC6972614
OpenAlexW2973915484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.